These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

314 related items for PubMed ID: 8605875

  • 1. Mouse oncostatin M: an immediate early gene induced by multiple cytokines through the JAK-STAT5 pathway.
    Yoshimura A, Ichihara M, Kinjyo I, Moriyama M, Copeland NG, Gilbert DJ, Jenkins NA, Hara T, Miyajima A.
    EMBO J; 1996 Mar 01; 15(5):1055-63. PubMed ID: 8605875
    [Abstract] [Full Text] [Related]

  • 2. CIS, a cytokine inducible SH2 protein, is a target of the JAK-STAT5 pathway and modulates STAT5 activation.
    Matsumoto A, Masuhara M, Mitsui K, Yokouchi M, Ohtsubo M, Misawa H, Miyajima A, Yoshimura A.
    Blood; 1997 May 01; 89(9):3148-54. PubMed ID: 9129017
    [Abstract] [Full Text] [Related]

  • 3. Transcriptional regulation of the beta-casein gene by cytokines: cross-talk between STAT5 and other signaling molecules.
    Chida D, Wakao H, Yoshimura A, Miyajima A.
    Mol Endocrinol; 1998 Nov 01; 12(11):1792-806. PubMed ID: 9817603
    [Abstract] [Full Text] [Related]

  • 4. Suppression of interleukin-3-induced gene expression by a C-terminal truncated Stat5: role of Stat5 in proliferation.
    Mui AL, Wakao H, Kinoshita T, Kitamura T, Miyajima A.
    EMBO J; 1996 May 15; 15(10):2425-33. PubMed ID: 8665850
    [Abstract] [Full Text] [Related]

  • 5. Activation of Jak-Stat and MAPK2 pathways by oncostatin M leads to growth inhibition of human glioma cells.
    Halfter H, Friedrich M, Postert C, Ringelstein EB, Stögbauer F.
    Mol Cell Biol Res Commun; 1999 May 15; 1(2):109-16. PubMed ID: 10356359
    [Abstract] [Full Text] [Related]

  • 6. Activation of the Jak-Stat- and MAPK-pathways by oncostatin M is not sufficient to cause growth inhibition of human glioma cells.
    Halfter H, Postert C, Friedrich M, Ringelstein EB, Stögbauer F.
    Brain Res Mol Brain Res; 2000 Sep 15; 80(2):198-206. PubMed ID: 11038252
    [Abstract] [Full Text] [Related]

  • 7. Physician Education: The Erythropoietin Receptor and Signal Transduction.
    Yoshimura A, Arai K.
    Oncologist; 1996 Sep 15; 1(5):337-339. PubMed ID: 10388012
    [Abstract] [Full Text] [Related]

  • 8. Erythropoietin induces tyrosine phosphorylation of the interleukin-3 receptor beta subunit (betaIL3) and recruitment of Stat5 to possible Stat5-docking sites in betaIL3.
    Chin H, Wakao H, Miyajima A, Kamiyama R, Miyasaka N, Miura O.
    Blood; 1997 Jun 15; 89(12):4327-36. PubMed ID: 9192755
    [Abstract] [Full Text] [Related]

  • 9. Induction of differentiation by IL-6-type cytokines is impaired in myeloid leukaemia cells unable to activate Stat5a.
    Piekorz RP, Hocke GM.
    Cytokine; 1997 Sep 15; 9(9):639-49. PubMed ID: 9325012
    [Abstract] [Full Text] [Related]

  • 10. Formation of autocrine loops in human cerebral meningioma tissue by leukemia inhibitor factor, interleukin-6, and oncostatin M: inhibition of meningioma cell growth in vitro by recombinant oncostatin M.
    Schrell UM, Koch HU, Marschalek R, Schrauzer T, Anders M, Adams E, Fahlbusch R.
    J Neurosurg; 1998 Mar 15; 88(3):541-8. PubMed ID: 9488310
    [Abstract] [Full Text] [Related]

  • 11. Duration of STAT5 activation influences the response of interleukin-2 receptor alpha gene to different cytokines.
    Imbert V, Renauld PR.
    Eur Cytokine Netw; 1999 Mar 15; 10(1):71-8. PubMed ID: 10210776
    [Abstract] [Full Text] [Related]

  • 12. STAT5 activation correlates with erythropoietin receptor-mediated erythroid differentiation of an erythroleukemia cell line.
    Iwatsuki K, Endo T, Misawa H, Yokouchi M, Matsumoto A, Ohtsubo M, Mori KJ, Yoshimura A.
    J Biol Chem; 1997 Mar 28; 272(13):8149-52. PubMed ID: 9079629
    [Abstract] [Full Text] [Related]

  • 13. Signaling induced by erythropoietin and stem cell factor in UT-7/Epo cells: transient versus sustained proliferation.
    Erickson-Miller CL, Pelus LM, Lord KA.
    Stem Cells; 2000 Mar 28; 18(5):366-73. PubMed ID: 11007921
    [Abstract] [Full Text] [Related]

  • 14. Mitogen-activated protein kinase plays an essential role in the erythropoietin-dependent proliferation of CTLL-2 cells.
    Sakamoto H, Kitamura T, Yoshimura A.
    J Biol Chem; 2000 Nov 17; 275(46):35857-62. PubMed ID: 10960479
    [Abstract] [Full Text] [Related]

  • 15. Interleukin 2 and erythropoietin activate STAT5/MGF via distinct pathways.
    Wakao H, Harada N, Kitamura T, Mui AL, Miyajima A.
    EMBO J; 1995 Jun 01; 14(11):2527-35. PubMed ID: 7781605
    [Abstract] [Full Text] [Related]

  • 16. Desensitization of the growth hormone-induced Janus kinase 2 (Jak 2)/signal transducer and activator of transcription 5 (Stat5)-signaling pathway requires protein synthesis and phospholipase C.
    Fernández L, Flores-Morales A, Lahuna O, Sliva D, Norstedt G, Haldosén LA, Mode A, Gustafsson JA.
    Endocrinology; 1998 Apr 01; 139(4):1815-24. PubMed ID: 9528967
    [Abstract] [Full Text] [Related]

  • 17. A possible involvement of Stat5 in erythropoietin-induced hemoglobin synthesis.
    Wakao H, Chida D, Damen JE, Krystal G, Miyajima A.
    Biochem Biophys Res Commun; 1997 May 08; 234(1):198-205. PubMed ID: 9168989
    [Abstract] [Full Text] [Related]

  • 18. Activation of the JAK1-STAT5 pathway by binding of the Friend virus gp55 glycoprotein to the erythropoietin receptor.
    Yamamura Y, Senda H, Noda M, Ikawa Y.
    Leukemia; 1997 Apr 08; 11 Suppl 3():432-4. PubMed ID: 9209415
    [Abstract] [Full Text] [Related]

  • 19. Oncostatin M and interleukin 6 inhibit cell cycle progression by prevention of p27kip1 degradation in HepG2 cells.
    Klausen P, Pedersen L, Jurlander J, Baumann H.
    Oncogene; 2000 Jul 27; 19(32):3675-83. PubMed ID: 10951574
    [Abstract] [Full Text] [Related]

  • 20. A novel cytokine-inducible gene CIS encodes an SH2-containing protein that binds to tyrosine-phosphorylated interleukin 3 and erythropoietin receptors.
    Yoshimura A, Ohkubo T, Kiguchi T, Jenkins NA, Gilbert DJ, Copeland NG, Hara T, Miyajima A.
    EMBO J; 1995 Jun 15; 14(12):2816-26. PubMed ID: 7796808
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.